Canada Consults On Customized Rules For Approving Unique Devices, Drugs
Executive Summary
Health Canada is inviting suggestions from stakeholders as it works on implementing a flexible approach for authorizing complex and novel health products. The regulator also draws up new clinical trial rules.
You may also be interested in...
Global Regulators Synergize Horizon Scanning Efforts
The International Coalition of Medicines Regulatory Authorities has established an innovation network to identify emerging technologies and develop internationally acceptable approaches for their regulation.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EMA Hopes New Requirement Will Make Companies Stick To Their Filing Plans
An additional form that marketing authorization applicants must now complete during the pre-submission stage emphasizes the importance of companies providing accurate information on their intended submission date.